November 21, 2017 9:40 AM ET


Company Overview of Enumeral Biomedical Holdings, Inc.

Key Executives for Enumeral Biomedical Holdings, Inc.

NameBoard RelationshipsTitleAge
Kevin G. Sarney CPA5 RelationshipsInterim CEO, Interim President, VP of Finance, Chief Accounting Officer, Treasurer & Director52
Barry C. Buckland Ph.D.48 RelationshipsCo-Founder & Chairman of Scientific Advisory Board69
Matthew A. Ebert No RelationshipsGeneral Counsel and Secretary--

Enumeral Biomedical Holdings, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Wael Fayad 5 RelationshipsEnumeral Biomedical Holdings, Inc.50
Kevin G. Sarney CPA 5 RelationshipsEnumeral Biomedical Holdings, Inc.52
Barry C. Buckland Ph.D. 48 RelationshipsEnumeral Biomedical Holdings, Inc.69
Robert L. Van Nostrand BS 37 RelationshipsYield10 Bioscience, Inc.60
Giulio Draetta M.D., Ph.D. 101 RelationshipsKaryopharm Therapeutics Inc.--
View All Board Members

Enumeral Biomedical Holdings, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Nominating Committee Ph.D.Barry C. Buckland48 Relationships2 Executives
Corporate Governance Committee Ph.D.Barry C. Buckland48 Relationships2 Executives
Advisory Board Ph.D.Barry C. Buckland48 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$310.0K
Compensation as of Fiscal Year 2016
Enumeral Biomedical Holdings, Inc. CEO Compensation
Industry Average


Denis Wad to Resign as Director of Biotron Limited
November 20, 2017 12:17 AM ET
Humanigen, Inc. Announces Executive Changes
November 16, 2017 10:03 PM ET
Novelion Therapeutics Inc. Announces Board Appointments
November 16, 2017 9:02 PM ET
Premier Biomedical Appoints Carl Eller as Marketing & Planning Vice-President
November 16, 2017 3:00 PM ET
Gt Biopharma, Inc. Appoints Shawn M. Cross as President and Chief Operating Officer
November 16, 2017 1:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enumeral Biomedical Holdings, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at